Impossible burger.

After Plant Blood Gets FDA Approval, the Impossible Burger Is Set to Hit Supermarket Shelves

Earlier this week, Beyond Meat announced stunningly high earnings for the second quarter of 2019. Impossible Foods has not yet gone public, but its popularity seems undeniable: The company has faced a burger shortage over the past few months after Burger King announced it would begin serving an Impossible Whopper in April. It’s gotten a major boost from celebrity investors including David Chang, Jay-Z, and Serena Williams.

July 31, 2019 | Source: New Food Economy | by H. Claire Brown

Impossible Foods’ signature plant blood ingredient “heme,” or soy leghemoglobin, has received FDA approval.

The neck-and-neck competition between Impossible Foods and Beyond Burger for domination of the fake burger market just got a little bit tighter. 

Earlier this week, Beyond Meat announced stunningly high earnings for the second quarter of 2019. Impossible Foods has not yet gone public, but its popularity seems undeniable: The company has faced a burger shortage over the past few months after Burger King announced it would begin serving an Impossible Whopper in April. It’s gotten a major boost from celebrity investors including David Chang, Jay-Z, and Serena Williams. Sales have risen by 81 percent on delivery platform GrubHub. 

Then, on Wednesday, the Food and Drug Administration approved soy leghemoglobin as a color additive. Soy leghemoglobin, which releases heme when heated, is the “plant blood” that lends Impossible Burgers their lifelike bloody quality; the ingredient’s FDA approval was seen as the last major hurdle before the product can join Beyond Burger on supermarket shelves.